Prestige Consumer Healthcare
PBH
49.63
+0.03
+0.06%
Prestige Consumer Healthcare
US · PBH
#2733 by market cap
Listed 1970
49.63
+0.03
+0.06%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Cuts Target Price to $70Market Newswire · 2026/11/6
-
Rating change
Analysts Offer Insights on NA Companies: Springer Nature AG & Co. KGaA (OtherSPGDF) and Prestige Consumer Healthcare (PBH)TipRanks · 2026/8/6
-
Company notice
Prestige Consumer Healthcare | 10-Q: Q2 2027 Earnings ReportSEC · 2026/11/5
-
Rating change
Research Alert: Pbh Q1: Revenue Up 25% To Cad2.1b On Stampede Deal; Maintains 2026 GuidanceMT Newswires · 2026/5/7
-
Rating change
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $86Market Newswire · 2026/3/23
-
Rating change
William Blair Maintains Prestige Consumer Healthcare(PBH.US) With Buy RatingMarket Newswire · 2026/8/6
-
Company notice
Prestige Consumer Healthcare | 8-K: Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter ResultsSEC · 2026/11/5
-
Company notice
Prestige Consumer Healthcare | 8-K: Current reportSEC · 2026/8/15
-
Rating change
Oppenheimer Downgrades Prestige Consumer Healthcare(PBH.US) to Hold RatingMarket Newswire · 2026/5/14
-
Rating change
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $72Market Newswire · 2026/8/8
-
Company notice
8-K: Prestige Consumer Healthcare | 8-K: Current reportSEC · 2026/8/6
-
Rating change
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Cuts Target Price to $72Market Newswire · 2026/5/15
-
Rating change
Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $65Market Newswire · 2026/5/7
-
Rating change
Prestige Consumer Healthcare: Buy Rating Reaffirmed Despite Soft Outlook, With Acquisitions and Undervalued Earnings Power Seen as Upside DriversTipRanks · 2026/5/14
-
Prestige Consumer Healthcare Down Over 17%, on Pace for Largest Percent Decrease Since May 2010 -- Data TalkDow Jones · 2026/11/6
-
Company notice
10-Q: Prestige Consumer Healthcare | 10-Q: Q1 2027 Earnings ReportSEC · 2026/8/6
-
Prestige Consumer Healthcare Shares Tumble on Cut to Outlook, Lower 2Q ProfitWSJ · 2026/11/6
-
Rating change
Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $65 From $77, Maintains Outperform RatingMT Newswires · 2026/5/7
-
Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth ConferenceGlobeNewswire · 2026/8/11
-
Premium Brands Holdings Gets TSX Approval for Normal Course Issuer Bid PBH.TDow Jones · 2026/10/14
-
Company notice
Prestige Consumer Healthcare | 4: Statement of changes in beneficial ownership of securitiesSEC · 2026/8/6
-
Company notice
Prestige Consumer Healthcare | 4: Statement of changes in beneficial ownership of securitiesSEC · 2026/8/6
-
Premium Brands Holdings: Board Approves NCIB for Repurchase of Up to 1M Common Shares PBH.TDow Jones · 2026/10/1
-
Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings ResultsGlobeNewswire · 2026/10/14
-
Prestige Consumer Healthcare Lifts Outlook After Strong Q1TipRanks · 2026/8/23
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Prestige Consumer Healthcare discussion 0 comments